Surgical Site Infections after Laparoscopic Bariatric Surgery: Is Routine Antibiotic Prophylaxis Required?

dc.contributor.authorAktas, Aydin
dc.contributor.authorKayaalp, Cuneyt
dc.contributor.authorGunes, Orgun
dc.contributor.authorKirkil, Cuneyt
dc.contributor.authorTardu, Ali
dc.contributor.authorAydin, Mehmet Can
dc.contributor.authorAygen, Erhan
dc.date.accessioned2026-08-12T17:19:48Z
dc.date.issued2021
dc.departmentFırat Üniversitesi
dc.description.abstractBackground: It is a challenging question, especially in bariatric surgery (BS), whether antibiotic prophylaxis is necessary in all cases; considering the serious consequences of surgical site infection (SSI) on the one hand and irrational use of antibiotics on the other. The aim of this study was to determine the need/rationale for antibiotic prophylaxis in patients undergoing laparoscopic bariatric surgery, especially low-risk patients. Methods: This retrospective analysis involved 313 morbidly obese patients (body Mass Index [BMI] >= 40) who underwent laparoscopic BS at three medical centers between September 2018 and June 2019. During the trial, no inducement was given to use antibiotics, and the centers had chosen whether to use prophylaxis. The U.S. Centers for Disease Control and Prevention (CDC)-2016 criteria were used for the diagnosis of SSI. Results: Antibiotic prophylaxis was given to 181 patients, and the SSI rate in the entire series was 4.5% (14/313). There was no significant difference in SSI between the group who received antibiotics and that who did not (2.8% versus 6.8%, respectively; p = 0.09). Post-operative intra-abdominal complications were the main independent determinant for SSIs (p < 0.001). Antibiotic prophylaxis did not have any significant effect on the rate of SSI caused by these complications (2.2% versus 3.8%, respectively; p = 0.50). The second independent factor was the rate of SSI in patients with super-obesity (BMI >= 60), particularly incisional SSIs (p < 0.001). Antibiotic prophylaxis did not produce any significant decrease in the rate of SSI in patients with a BMI < 60 (2.8% versus 5.5%, respectively; p = 0.24). When these two independent factors were excluded, there were no patients with SSI in the no-antibiotics group, and only one in the antibiotic prophylaxis group (0.5%) (p = 1.00). Conclusions: Routine antibiotic prophylaxis should be questioned in laparoscopic BS. Prophylaxis may reduce incisional SSI in patients with a BMI of >= 60. In other cases, antibiotic prophylaxis does not provide a decrease in SSI
dc.identifier.doi10.1089/sur.2020.426
dc.identifier.endpage712
dc.identifier.issn1096-2964
dc.identifier.issn1557-8674
dc.identifier.issue7
dc.identifier.orcid0000-0002-0557-1369
dc.identifier.orcid0000-0003-3407-0210
dc.identifier.orcid0000-0002-0576-6086
dc.identifier.orcid0000-0002-0159-9356
dc.identifier.pmid33416442
dc.identifier.scopus2-s2.0-85114352608
dc.identifier.scopusqualityQ2
dc.identifier.startpage705
dc.identifier.urihttps://doi.org/10.1089/sur.2020.426
dc.identifier.urihttps://hdl.handle.net/11508/53329
dc.identifier.volume22
dc.identifier.wosWOS:000606626400001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMary Ann Liebert, Inc
dc.relation.ispartofSurgical Infections
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectantibiotic prophylaxis
dc.subjectmorbid obesity
dc.subjectone-anastomosis gastric bypass
dc.subjectRoux-en-Y gastric bypass
dc.subjectsleeve gastrectomy
dc.titleSurgical Site Infections after Laparoscopic Bariatric Surgery: Is Routine Antibiotic Prophylaxis Required?
dc.typeArticle

Dosyalar